End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.09 USD | 0.00% | 0.00% | -6.41% |
02-25 | Birzeit Pharmaceuticals Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-09 | What does the Gotham City report say about Grifols? | RE |
Sales 2022 | 47.03M 64.29M | Sales 2023 | 43.13M 58.95M | Capitalization | 169M 232M |
---|---|---|---|---|---|
Net income 2022 | 7M 9.57M | Net income 2023 | 6M 8.2M | EV / Sales 2022 | 3.31 x |
Net cash position 2022 | 15.41M 21.06M | Net cash position 2023 | 17.19M 23.49M | EV / Sales 2023 | 3.53 x |
P/E ratio 2022 |
21.5
x | P/E ratio 2023 |
27.3
x | Employees | - |
Yield 2022 |
2.27% | Yield 2023 |
-
| Free-Float | 73.92% |
Current month | -2.39% | ||
1 month | +1.24% | ||
3 months | -6.41% | ||
6 months | -2.62% | ||
Current year | -6.41% |
Managers | Title | Age | Since |
---|---|---|---|
Talal Nasereddin
CEO | Chief Executive Officer | 74 | 84-03-31 |
Director of Finance/CFO | - | 84-11-14 | |
Chief Tech/Sci/R&D Officer | - | 97-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 20-12-31 | |
Chief Administrative Officer | 54 | 91-12-31 | |
Talal Nasereddin
CEO | Chief Executive Officer | 74 | 84-03-31 |
1st Jan change | Capi. | |
---|---|---|
-6.41% | 159M | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- BPC Stock